Archivio istituzionale della ricerca dell'Università degli Studi di Palermo

GEBBIA, Vittorio
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 6.556
EU - Europa 2.178
AS - Asia 1.058
SA - Sud America 123
AF - Africa 23
OC - Oceania 8
Continente sconosciuto - Info sul continente non disponibili 5
Totale 9.951
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 6.529
IT - Italia 703
SG - Singapore 445
CN - Cina 394
UA - Ucraina 311
FI - Finlandia 228
DE - Germania 215
IE - Irlanda 162
GB - Regno Unito 152
RU - Federazione Russa 119
BR - Brasile 103
SE - Svezia 95
FR - Francia 64
HK - Hong Kong 55
IN - India 41
TR - Turchia 30
PL - Polonia 24
RO - Romania 21
AT - Austria 20
NL - Olanda 19
KR - Corea 18
BE - Belgio 17
MX - Messico 12
CA - Canada 11
IR - Iran 8
UZ - Uzbekistan 8
CI - Costa d'Avorio 7
IQ - Iraq 7
JP - Giappone 7
MA - Marocco 7
MY - Malesia 7
AU - Australia 6
GR - Grecia 6
VE - Venezuela 6
CH - Svizzera 5
PH - Filippine 5
ES - Italia 4
IL - Israele 4
AR - Argentina 3
BH - Bahrain 3
CO - Colombia 3
EU - Europa 3
JM - Giamaica 3
KE - Kenya 3
KW - Kuwait 3
A2 - ???statistics.table.value.countryCode.A2??? 2
AE - Emirati Arabi Uniti 2
BD - Bangladesh 2
BG - Bulgaria 2
BO - Bolivia 2
DK - Danimarca 2
EC - Ecuador 2
EG - Egitto 2
ID - Indonesia 2
KZ - Kazakistan 2
LT - Lituania 2
LV - Lettonia 2
NZ - Nuova Zelanda 2
PK - Pakistan 2
PY - Paraguay 2
SA - Arabia Saudita 2
TN - Tunisia 2
AO - Angola 1
AZ - Azerbaigian 1
CL - Cile 1
DZ - Algeria 1
EE - Estonia 1
HR - Croazia 1
HU - Ungheria 1
JO - Giordania 1
LB - Libano 1
LK - Sri Lanka 1
MM - Myanmar 1
MO - Macao, regione amministrativa speciale della Cina 1
MT - Malta 1
OM - Oman 1
PA - Panama 1
PS - Palestinian Territory 1
RS - Serbia 1
TH - Thailandia 1
TW - Taiwan 1
UY - Uruguay 1
VN - Vietnam 1
Totale 9.951
Salva come PNG Salva come JPEG
Città #
Fairfield 1.081
Ashburn 572
Woodbridge 563
Houston 498
Chandler 468
Seattle 413
Wilmington 413
Cambridge 352
Singapore 309
Ann Arbor 282
Jacksonville 169
Dublin 162
Palermo 161
Medford 154
Des Moines 118
Altamura 117
Princeton 97
Lawrence 88
Nanjing 86
Santa Clara 71
San Diego 68
Boardman 52
Hong Kong 50
Dearborn 49
Tulsa 47
Beijing 39
London 37
Shenyang 33
Milan 31
Hebei 29
Helsinki 25
Ludwigshafen am Rhein 25
Nanchang 23
Changsha 22
Saint Petersburg 21
Columbus 19
New York 19
Brussels 17
Jinan 17
Redwood City 17
San Paolo di Civitate 16
Seongnam 16
The Dalles 16
Chicago 15
Jiaxing 15
San Mateo 15
Izmir 14
Kumar 14
Nuremberg 14
Rome 14
Tianjin 14
Falls Church 13
Berlin 12
Ningbo 12
Polska 11
Council Bluffs 10
Dallas 10
Guangzhou 10
Los Angeles 10
Warsaw 10
Kunming 9
Moscow 9
Phoenix 9
Zhengzhou 9
Düsseldorf 8
Frankfurt am Main 8
Kilburn 8
Abidjan 7
Bremen 7
Florence 7
Springfield 7
São Paulo 7
Atlanta 6
Munich 6
Orange 6
Rho 6
Venice 6
Verona 6
Vienna 6
Washington 6
Ankara 5
Curitiba 5
Kochi 5
Monreale 5
New Delhi 5
Sandston 5
Tappahannock 5
Tashkent 5
Falkenstein 4
Frankfurt 4
Hangzhou 4
Istanbul 4
Mérida 4
Naples 4
Norwalk 4
Paris 4
Porto Alegre 4
Rio de Janeiro 4
Taiyuan 4
Taizhou 4
Totale 7.306
Salva come PNG Salva come JPEG
Nome #
Switching from morphine to methadone to improve analgesia and tolerability in cancer patients: A prospective study 312
Does pain intensity predict a poor opioid response in cancer patients? 211
Subcutaneous octreotide versus oral loperamide in the treatment of diarrhea following chemotherapy 193
Adjuvant anastrozole versus exemestane versus letrozole, upfront or after 2 years of tamoxifen, in endocrine-sensitive breast cancer (FATA-GIM3): a randomised, phase 3 trial 193
Gastric and Rectal Metastases from Malignant Melanoma Presenting with Hypochromic Anemia and Treated with Immunotherapy 175
Cancer pain management in an oncological ward in a comprehensive cancer center with an established palliative care unit. 159
Adherence, compliance and persistence to oral antineoplastic therapy: A review focused on chemotherapeutic and biologic agents 159
Phase III randomized trial of FOLFIRI versus FOLFOX4 in the treatment of advanced colorectal cancer: a multicenter study of the Gruppo Oncologico Dell'Italia Meridionale 151
Safety of a 3-weekly schedule of carboplatin plus pegylated liposomal doxorubicin as first line chemotherapy in patients with ovarian cancer: preliminary results of the MITO-2 randomized trial. 151
Metronomic chemotherapy (mCHT) in HER2-ve advanced breast cancer (ABC) patients (pts): What has changed over the time? Preliminary results of the VICTOR-6 study 147
Cetuximab and gemcitabine in elderly or adult PS2 patients with advanced non-small-cell lung cancer: The cetuximab in advanced lung cancer (CALC1-E and CALC1-PS2) randomized phase II trials. 146
Informal caregiving burden in advanced non-small cell lung cancer: the HABIT study. 140
Second-line chemotherapy in advanced pancreatic carcinoma: a multicenter survey of the Gruppo Oncologico Italia Meridionale on the activity and safety of the FOLFOX4 regimen in clinical practice. 138
Carboplatin plus paclitaxel versus carboplatin plus pegylated liposomal doxorubicin as first-line treatment for patients with ovarian cancer: The MITO-2 randomized phase III trial 137
ELF regimen in advanced gastrointestinal malignancies: An analysis of its clinical effectiveness and toxicity 137
Pretreatment quality of life and functional status assessment significantly predict survival of elderly patients with advanced non-small-cell lung cancer receiving chemotherapy: a prognostic analysis of the multicenter Italian lung cancer in the elderly study 136
Oral versus intravenous vinorelbine: clinical safety profile 136
Abemaciclib: safety and effectiveness of a unique cyclin-dependent kinase inhibitor 136
Etoposide, doxorubicin (Adriamycin) and cisplatin regimen in advanced gastric adenocarcinoma: experience with a lower dose schedule 135
Efficacy and safety of cetuximab/irinotecan in chemotherapy-refractory metastatic colorectal adenocarcinomas: a clinical practice setting, multicenter experience 133
Anticancer oral therapy: Emerging related issues 132
Is There Still a Role for Endocrine Therapy Alone in HR+/HER2- Advanced Breast Cancer Patients? Results from the Analysis of Two Data Sets of Patients Treated with High-Dose Fulvestrant as First-Line Therapy in the Real-World Setting: The EVA and GIM-13 AMBRA Studies 132
Raltitrexed plus levofolinic acid and bolus/continuous infusion 5- Fluorouracil on a biweekly schedule for elderly patients with advanced colorectal carcinomas 130
Chemotherapy-induced neutropenia and treatment efficacy in advanced non-small-cell lung cancer: a pooled analysis of three randomised trials 129
Treatment of metastatic breast cancer with vinorelbine and docetaxel 129
Oral vinorelbine may not induce acute pain at the tumor site. 128
Treatment of advanced non-small cell lung cancer: chemotherapy with or without cisplatin? 126
Cetuximab in squamous cell head and neck carcinomas. 126
Metronomic Chemotherapy (mCHT) in HER2-ve Advanced Breast Cancer (ABC) Patients (PTS): When Care Objectives Meet Patients’ Need. Preliminary Results of the Victor-6 Study 126
Adjuvant chemotherapy with epirubicin, leucovorin, 5-fluorouracil and etoposide regimen in resected gastric cancer patients: a randomized phase III trial by the Gruppo Oncologico Italia Meridionale (GOIM 9602 Study). 124
Tools for identifying cancer pain of predominantly neuropathic origin and opioid responsiveness in cancer patients. 124
Primary extranodal non-Hodgkin lymphomas of the uterus and the breast: report of three cases 123
Non small cell lung cancer patients with ECOG PS2: unsolved questions and lessons from clinical trials 122
Neoadjuvant chemotherapy for stage IIIA-N2 non-small cell lung cancer 121
Breakthrough pain in oncology: a longitudinal study. 121
A prospective evaluation of the activity of human granulocyte-colony stimulating factor on the prevention of chemotherapy-related neutropenia in patients with advanced carcinoma 120
Factorial phase III randomised trial of rofecoxib and prolonged constant infusion of gemcitabine in advanced non-small-cell lung cancer: the GEmcitabine-COxib in NSCLC (GECO) study. 116
A randomized trial comparing tamoxifen therapy vs. tamoxifen prophylaxis in bicalutamide-induced gynecomastia. 116
WHATSAPP MESSENGER AS A REAL-TIME TOOL FOR A LONG-DISTANCE ACTIVITY OF A MULTIDISCIPLINARY 116
Combination chemotherapy of 5-Fluorouracil, Epidoxorubicin and Mitomicin C in the palliative treatment of locally-advanced and/or metastatic adenocarcinoma of the stomach. 116
Subcutaneous recombinant human erythropoietin prevents chemotherapy-related anemia in patients with advanced cancer. 112
Gastric metastasis from breast cancer 112
Cetuximab: clinical results in colorectal cancer. 108
Reactions and countermeasures of medical oncologists towards the incoming COVID-19 pandemic: A whatsapp messenger-based report from the Italian college of chief medical oncologists 108
Irinotecan (CPT-11) and mitomycin-C (MMC) as second-line therapy in advanced gastric cancer: a phase II study of the Gruppo Oncologico dell' Italia Meridionale (prot. 2106). 107
Efficacy and safety of Everolimus and Exemestane in hormone-receptor positive (HR+) human-epidermal-growth-factor negative (HER2−) advanced breast cancer patients: New insights beyond clinical trials. The EVA study 107
Phase II study of sequential hormonal therapy with anastrozole/exemestane in advanced and metastatic breast cancer 106
FOLFIRI with or without celecoxib in advanced colorectal cancer: a randomized phase II study of the Gruppo Oncologico dell'Italia Meridionale (GOIM) 106
Italian clinical research in non-small-cell lung cancer 105
Weekly levofolinic acid and 5-fluorouracil plus hydroxyurea in metastatic gastrointestinal adenocarcinomas 104
Quality of life analysis of TORCH, a randomized trial testing first-line erlotinib followed by second-line cisplatin/gemcitabine chemotherapy in advanced non-small-cell lung cancer 103
Salvage Therapy With Oral Metronomic Cyclophosphamide and Methotrexate for Castration refractory Metastatic Adenocarcinoma of the Prostate Resistant to Docetaxel 102
Ondasetron versus granisetron in the prevention of chemotherapy‐induced nausea and vomiting. Results of a prospective randomized trial 102
Everolimus (EVE) and exemestane (EXE) in patients with advanced breast cancer aged ≥ 65 years: New lessons for clinical practice from the EVA study 99
Validation of the AJCC prognostic stage for HER2-positive breast cancer in the ShortHER trial 97
Topotecan plus ifosfamide in patients with platinum refractory advanced/metastatic non-small cell lung cancer: a phase II trial 96
Sustained-release oral morphine versus transdermal fentanyl and oral methadone in cancer pain management. 92
“Randomised, open-label, phase II trial of paclitaxel, gemcitabine and cisplatin versus gemcitabine and cisplatin as first-line chemotherapy in advanced transitional cell carcinoma of the urothelium” 91
Metronomic oral vinorelbine in patients with advanced non-small cell lung cancer progressing after nivolumab immunotherapy: a retrospective analysis 90
Opioid plasma concentration during switching from morphine to methadone: Preliminary data 89
Weekly 5-fluorouracil and folinic acid plus escalating doses of cisplatin with gluthatione protection in patients with advanced head and neck cancer 85
Radium-223 treatment in castration resistant bone metastatic prostate cancer. Should be the primary tumor always treated? 83
Nine weeks versus 1 year adjuvant trastuzumab in combination with chemotherapy: Final results of the phase III randomized Short-HER study 83
Carboplatin in combination with raltitrexed in recurrent and metastatic head and neck squamous cell carcinoma: A multicentre phase II study of the Gruppo Oncologico Dell'Italia Meridionale (G.O.I.M.) 80
A phase i-II study of cyclophosphamide, epidoxorubicin, levofolinic acid/5-fluorouracil and recombinant human granulocyte colony stimulating factor in metastatic breast carcinoma 79
Activity and toxicity of oxaliplatin plus raltitrexed in 5-fluorouracil refractory metastatic colorectal adeno-carcinoma 78
Metronomic chemotherapy for advanced breast cancer patients in the real world practice: Final results of the VICTOR-6 study 78
Oral metronomic cyclophosphamide with and without methotrexate as palliative treatment for patients with metastatic breast carcinoma 77
Liability of clinical oncologists and the COVID-19 emergency: Between hopes and concerns 77
MISURARE LA FRAGILITÀ DEL PAZIENTE ONCOLOGICO ANZIANO 75
Eribulin Mesylate for the Treatment of Metastatic Hormone-refractory and Triple-negative Breast Cancer: A Multi-institutional Real-world Report on Efficacy and Safety 75
FOLFIRI regimen in advanced colorectal cancer: the experience of the Gruppo Oncologico dell'Italia Meridionale 73
High-dose Radiotherapy for Oligo-progressive NSCLC Receiving EGFR Tyrosine Kinase Inhibitors: Real World Data 70
GEMCITABINE AND CISPLATIN FOR INOPERABLE AND/OR METASTATIC BILIARY TREE CARCINOMAS: A MULTICENTER PHASE II STUDY OF THE GRUPPO ONCOLOGICO DELL'ITALIA MERIDIONALE (GOIM) 68
Morphine versus oxycodone in pancreatic cancer pain: a randomized controlled study. 68
Stereotactic Radiotherapy for the Treatment of Patients With Oligo-progressive Metastatic Renal Cell Carcinoma Receiving Vascular Endothelial Growth Factor Receptor Tyrosine Kinase Inhibitor: Data From the Real World 67
Short term intensive preoperative chemotherapy with high doses of epirubicin plus G-CSF rescue for locally advanced Stage III breast carcinoma. 66
Impressive objective response to nab-paclitaxel plus trastuzumab as fifth line therapy in aelderly her2-positive breast cancer patient 66
Vinorelbine plus cisplatinum for the treatment of Stage IIIB and IV Non Small Cell Lung Carcinoma. 65
Safety and efficacy of the treatment with Nab-paclitaxel in mEtastatic bREast cancer In elDerly patiEnts: NEREIDE study 65
NEPA as antiemetic prophylaxis after failure of 5HT3-RA plus dexamethasone in patients receiving carboplatin and gemcitabine chemotherapy: A monocentric real-life experience 65
Virtual clinical and precision medicine tumor boards-cloud-based platform-mediated implementation of multidisciplinary reviews among oncology centers in the covid-19 era: Protocol for an observational study 65
UN NUOVO INDICE PROGNOSTICO-TERAPEUTICO IN ONCOLOGIA GERIATRICA 64
Vinorelbine and 5-fluorouracil bolus and/or continuous venous infusion plus levofolinic acid as second-line chemotherapy for metastatic breast cancer: an analysis of results in clinical practice of the Gruppo Oncologico Italia Meridionale (GOIM) 64
Oral vinorelbine in the treatment of non-small cell lung cancer: rationale and implications for patient management. 59
Abemaciclib-associated Diarrhea: An Exploratory Analysis of Real-life Data 58
Is G8 geriatric assessment tool useful in managing elderly patients with metastatic pancreatic carcinoma? 55
Mitoxantrone + Prednisone versus Taxotere + Prednisone nel trattamento del carcinoma prostatico ormonorefrattario (cpor ). Studio randomizzato di fase II del Gruppo Oncologico dell’Italia Meridionale (GOIM ). VII CONGRESSO NAZIONALE G.O.I.M. ROMA 23-25 Giugno 2004 54
Chemotherapy for endometrial carcinoma 53
Harmful Interference of Detoxifying Diets and Nutraceuticals with Adherence to Abemaciclib in Advanced Estrogen Receptor-Positive, Human Epidermal Growth Factor Receptor-2-Negative Breast Cancer: A Case Report 53
Levo folinic acid and 5-fluorouracil plus high dose epidoxorubicin as first line treatment for metastatic breast carcinoma 52
Correlation between sentinel lymph node biopsy and non-sentinel lymph node metastasis in patients with cN0 breast carcinoma: comparison of invasive ductal carcinoma and invasive lobular carcinoma 51
Patients With Cancer and COVID-19: A WhatsApp Messenger-Based Survey of Patients' Queries, Needs, Fears, and Actions Taken 51
Second-line Eribulin in Triple Negative Metastatic Breast Cancer patients. Multicentre Retrospective Study: The TETRIS Trial 50
Cancer: New needs, new models. is it time for a community oncologist? another brick in the wall 43
Virtual Multidisciplinary Tumor Boards: A Narrative Review Focused on Lung Cancer 40
A Prospective Observational Study on the Structuring Process and Implementation of a Large Regional, Inter-hospital, Virtual Multidisciplinary Tumor Board on Prostate Cancer 36
Latissimus Dorsi Flap and Thoracodorsal Artery Perforator Flap with Immediate Fat Transfer (LIFT and TIFT): A Retrospective Study about Total Breast Reconstruction in High-Risk Patients 34
Management of Patients with Gastric or Gastroesophageal Junction Cancer: From Theory to Integrated Clinical Path- ways Implementation in the Real World 33
The Impact of Neoadjuvant Chemotherapy on Axillary Surgical Management of Patients With Breast Cancer and Positive Axillary Lymph Nodes 31
Totale 10.227
Salva come PNG Salva come JPEG
Categoria #
all - tutte 44.440
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 44.440
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020373 0 0 0 0 0 0 0 0 0 123 159 91
2020/20211.745 109 113 281 129 197 81 129 94 130 175 147 160
2021/20221.196 79 260 13 62 58 42 69 57 145 149 62 200
2022/20231.411 134 321 27 126 162 232 91 80 136 12 46 44
2023/2024602 29 97 67 48 37 92 46 27 12 15 40 92
2024/20251.199 50 166 183 144 96 60 130 109 124 137 0 0
Totale 10.457